Liprotamase

N/A

Report date: 2022/11/25 17:24:24

Base Information

Drug NameLiprotamase
Drug Alias Name利普他酶TheraCLECTrizytekSollpuraLY-3031642 +[6] 
ClassificationBiologics > Protein drugs > Enzyme > Recombinant enzymeBiologics > Protein drugs > Recombinant protein > Recombinant enzyme
Mechanisms of ActionPancrelipase replacements
TargetsPancrelipase
Therapy Area/IndicationsExocrine Pancreatic InsufficiencyCystic Fibrosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCzechiaCanadaUnited States +[9] 
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesCystic Fibrosis Foundation Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAnthera Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsExocrine Pancreatic InsufficiencyCystic Fibrosis

Other Information

ATC CodeN/A
Related LinksN/A